Biotech Bros artwork

Acquisitions in the $XBI, a Second Chance at bat for $AMLX, and a Potential Cure for Huntington's

Biotech Bros

English - July 18, 2022 12:00 - 57 minutes - 39.6 MB
Investing Business Health & Fitness Medicine biotech investing money finance get rich markets comedy health healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors
Next Episode: Aggressive Management for $LPTX and Fraud in Alzheimer's and $SAVA

This week on the podcast Agustin discusses the recent acquisition activity in the biotech space, some positive news for Amylyx Pharmaceuticals regarding a new chance to convince regulators of an approval at their second ad-board, and an incredible data readout for a new gene therapy targeting Huntington's Disease. 


If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com

All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...

Listen on: Apple Podcasts   Spotify

If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com

Twitter Mentions